title: Optogenetic control of cardiomyocytes via viral delivery.
abstract: Optogenetics is an emerging technology for the manipulation and control of excitable tissues, such as the brain and heart. As this technique requires the genetic modification of cells in order to inscribe light sensitivity, for cardiac applications, here we describe the process through which neonatal rat ventricular myocytes are virally infected in vitro with channelrhodopsin-2 (ChR2). We also describe in detail the procedure for quantitatively determining the optimal viral dosage, including instructions for patterning gene expression in multicellular cardiomyocyte preparations (cardiac syncytia) to simulate potential in vivo transgene distributions. Finally, we address optical actuation of ChR2-transduced cells and means to measure their functional response to light.
authors: Department of Biomedical Engineering, Institute for Molecular Cardiology, Stony Brook University, BST-6, Room 120B, Stony Brook, NY, 11794-8661, USA.
authors: Christina M
authors: CM
authors: Ambrosi
authors: Emilia
authors: E
authors: Entcheva
mesh_terms: D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D006352:Heart Ventricles / Q000166:cytology; D032383:Myocytes, Cardiac / Q000378:metabolism*; D062308:Optogenetics / Q000379:methods*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012243:Rhodopsin / Q000235:genetics; D014161:Transduction, Genetic / Q000379:methods*; D019076:Transgenes / Q000235:genetics
chemical_list: D012243:Rhodopsin